Point72 Hong Kong’s Genomic Health, Inc. GHDX Stock Holding History

Point72 Hong Kong’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-14	Closed	-$1K	–	1592
2019 Q3	$1K	Buy	+14	New	+$961	﹤0.01%	949
2019 Q2	–	Sell	-34	Closed	-$2K	–	1552
2019 Q1	$2K	Buy	+34	New	+$2.52K	﹤0.01%	922
2018 Q3	–	Sell	-26	Closed	-$1K	–	1335
2018 Q2	$1K	Buy	+26	New	+$1.03K	﹤0.01%	860
2017 Q4	–	Sell	-357	Closed	-$11K	–	1219
2017 Q3	$11K	Buy	+357	New	+$11.3K	0.01%	482

Point72 Hong Kong's GHDX Position: Q4 2019 in Review

Point72 Hong Kong sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 14 shares — an estimated $1K sold.

Point72 Hong Kong first reported a position in GHDX in Q3 2017 and held it in 4 quarters. The position peaked at $11K in Q3 2017. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Point72 Hong Kong reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Point72 Hong Kong sold 14 Genomic Health, Inc. shares in Q4 2019, an estimated $1K.
Point72 Hong Kong first reported a position in Genomic Health, Inc. in Q3 2017 and held it in 4 quarters.
Point72 Hong Kong's Genomic Health, Inc. position peaked at $11K in Q3 2017.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Point72 Hong Kong's 13F filing for Q4 2019, filed 14 Feb 2020.